Stress and treatment results in stomach cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how psychological stress affects treatment success and long-term outcomes in people with stomach cancer. It includes three different groups of patients at various stages of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with adenocarcinoma of the stomach (a common type of stomach cancer)
- You are able to perform daily activities with little or no help (ECOG score 0 or 1)
- You do not have other serious illnesses or uncontrolled medical conditions
- You have not had cancer treatment before (chemotherapy, radiation, immunotherapy, or targeted therapy) for this cancer
- You have not had another type of cancer at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how psychological distress relates to immune checkpoint inhibitors in people with stomach cancer. It may help understand if emotional well-being affects treatment response.
This study looks at how emotional distress before treatment affects how well the tumor responds to chemotherapy and surgery in people with stomach or gastroesophageal junction cancer. It may help understand if mental health impacts treatment outcomes.
This trial studies how psychological stress might affect the success of pre-surgery breast cancer treatments (neoadjuvant therapy). If you are about to start treatment and have never had cancer therapy before, this study could help doctors understand your response better.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study looks at whether chronic stress changes how well immunotherapy (ICI therapy) works in people with esophageal cancer. It may help doctors understand who benefits most from treatment and how stress could affect outcomes.
This study looks at whether psychological stress changes how well lung cancer treatments work and what the outlook is. You may qualify if you’re about to start (or recently started) certain immunotherapy-based treatments, and you can complete stress and well-being questionnaires.
Hear when a new Gastric Cancer, Gastroesophageal Junction Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.